Tumor cells chronically treated with a trastuzumab-maytansinoid antibody-drug conjugate develop varied resistance mechanisms but respond to alternate treatments
长期用曲妥珠单抗-美登木素抗体药物偶联物治疗的肿瘤细胞会产生多种耐药机制,但对替代治疗有反应
期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-14-0862
Frank Loganzo, Xingzhi Tan, Matthew Sung, Guixian Jin, Jeremy S Myers, Eugene Melamud, Fang Wang, Veronica Diesl, Maximillian T Follettie, Sylvia Musto, My-Hanh Lam, William Hu, Manoj B Charati, Kiran Khandke, Kenny Sung Kyoo Kim, Mike Cinque, Judy Lucas, Edmund Graziani, Andreas Maderna, Christophe